| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/14/2001 | CA2036222C Plating compositions and processes |
| 08/09/2001 | WO2001057046A1 Method of converting functional group through halogen-metal exchange reaction |
| 08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001056991A1 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 08/09/2001 | WO2001056990A2 Pyridine derivates as potentiators of glutamate receptors |
| 08/09/2001 | WO2001056988A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001056538A1 Novel coupler for use in oxidative hair dyeing |
| 08/09/2001 | WO2001056358A2 Enhanced propertied pesticides |
| 08/09/2001 | WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2001014376A8 Novel spiro compounds |
| 08/09/2001 | WO2001010834A9 Antibacterial agents |
| 08/09/2001 | WO2000071511A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2000071506A3 Naphthalene ureas as glucose uptake enhancers |
| 08/09/2001 | WO2000059878A3 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 08/09/2001 | WO2000047554A3 INHIBITORS OF FACTOR Xa |
| 08/09/2001 | US20010012897 Substituted thiopyridines |
| 08/09/2001 | US20010012892 Method for producing a heterocyclic nitrile |
| 08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/09/2001 | US20010012848 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor |
| 08/09/2001 | DE10005150A1 Verfahren zur Herstellung von 5-Arylnicotinaldehyden A process for the preparation of 5-Arylnicotinaldehyden |
| 08/09/2001 | CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | CA2368540A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | CA2368151A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/08/2001 | EP1122244A1 Uracil compounds and their use |
| 08/08/2001 | EP1122242A1 Cyanophenyl derivatives |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121121A2 Methods for inhibiting diabetic complications |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | CN1307471A Use of NMDA antagonists for treatment of irritable bowel syndrome |
| 08/07/2001 | US6271418 Process for preparing (hetero) aromatic substituted benzene derivatives |
| 08/07/2001 | US6271400 Silicon based anhydrous oxidant; ligand; catalytic organo or inorgano rhenium oxide; controlling excess water concentration and maximizing monoperoxocomplex formation. |
| 08/07/2001 | US6271379 Intermediates useful for the synthesis of huperzine A |
| 08/07/2001 | US6271376 Process for the preparation of N-(amino-4,6-dihalo-pyrimidine) formamides |
| 08/07/2001 | US6271372 Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 08/07/2001 | US6271247 Binding to neuropeptide receptors |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy |
| 08/07/2001 | US6271236 Diaminopyridine-containing thiourea inhibitors of herpes virus |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271234 1,4-disubstituted piperazines |
| 08/07/2001 | CA2049440C Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| 08/04/2001 | CA2646796A1 Hydroxypyridine compounds useful as intermediates |
| 08/02/2001 | WO2001055175A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055114A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 08/02/2001 | WO2001055113A1 Processes for dechlorinating pyridines |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2001055109A1 Aromatic amides acting on melanocortin receptors |
| 08/02/2001 | WO2001055107A2 Aromatic amines and amides acting on the melanocortin receptors |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001055095A1 Functional monomers for molecular recognition and catalysis |
| 08/02/2001 | WO2001055085A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001055067A1 Method for preparing alpha-halogenated ketones |
| 08/02/2001 | WO2001054501A2 Herbicidal composition |
| 08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
| 08/02/2001 | WO2001005766A3 Process for the preparation of 3,5-dichloropyridine |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | US20010011136 Anticancer agents |
| 08/02/2001 | US20010011135 Anticancer agents |
| 08/02/2001 | US20010011091 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2397831A1 Enhanced propertied pharmaceuticals |
| 08/02/2001 | CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/01/2001 | EP1120410A1 Nicotinic acid esters useful as CNS agents and having affinity for 5-HT receptors |
| 08/01/2001 | EP1120409A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 08/01/2001 | EP1120114A2 Compositions and methods for treating conditions responsive to estrogen |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119543A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 08/01/2001 | CN1306528A Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, its prodn. method and applications |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306513A Improved method for producing substituted pyridine-carboxylic acids |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306509A Substituted benzamides, their prodn. and use as cysteine protease inhibitors |
| 08/01/2001 | CN1306505A Substituted benzamides, their prodn. and use |
| 08/01/2001 | CN1306425A Process for synthesizing Cox-2 inhibitors |
| 07/31/2001 | US6268503 Reacting 2-(4-bromomethylphenyl)pyridine salt or 2-(4-dibromomethylphenyl)pyridine with hexamethylenetetramine and water to provide 4-(pyridin-2-yl)benzaldehyde |
| 07/31/2001 | US6268502 Process of synthesis of 5-methoxy- 2-[(4-methoxy-3,5-dimethy-2-pyridyl)methyl]sulfiny-1h-benzimidazole |
| 07/31/2001 | US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis. |
| 07/31/2001 | US6268384 Compounds possessing neuronal activity |
| 07/31/2001 | US6268365 Src family SH2 domain inhibitors |
| 07/31/2001 | US6268357 Organic vanadium (III) complexes and their use |
| 07/31/2001 | US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053275A2 Substituted aryl ketones |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053260A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001052829A2 Statin-type bone growth stimulators |
| 07/26/2001 | WO2001046180A8 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001004097A3 Cyclic delocalized cations connected by spacer groups |